ORIC Pharmaceuticals Shares Move Higher After Equity Infusion, Clinical Collaboration From Pfizer
ORIC Pharmaceuticals Inc (NASDAQ:ORIC) entered a clinical development collaboration for a potential Phase 2 study of ORIC-533 in multiple myeloma with Pfizer…